Morgan Stanley analyst Dara Mohsenian upgraded Colgate-Palmolive to Overweight from Equal Weight with an unchanged price target of $82. The near 10% pullback in shares over the last month offers a buying opportunity "into a structurally attractive name," the analyst tells investors in a research note. The firm believes Colgate’s conservative 2023 earnings guidance should allow the company to beat lowered consensus forecasts. Colgate is Morgan Stanley’s top household products pick as it sees robust pricing power, strong pet trends and positive corporate strategy changes.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on CL:
- Are You Seeking Passive Income? Try These 2 Dividend Kings
- Colgate-Palmolive (NYSE:CL) Reported Earnings: Did It Beat Estimates?
- Colgate-Palmolive sees 2023 net sales growth 2%-5%, consensus $18.61B
- Colgate-Palmolive reports Q4 base EPS 77c, consensus 76c
- Notable companies reporting before tomorrow’s open